Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4/A Open-market sale Director sold 62,925 shares at $29.70 ($1,869,168)
  2. 4 Open-market sale President sold 100,000 shares at an average $35.02 ($3,502,385)
  3. 4 Grant or award Chief Business Officer acquired 20,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy 10% owner bought 40,198 shares at an average $24.93 ($1,002,194)
  6. 4 Open-market buy 10% owner bought 90,742 shares at an average $24.08 ($2,184,960)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 72,934 shares at an average $29.85 ($2,176,898)
  9. 4 Exercise or conversion Chief Executive Officer acquired 21,500 shares (option exercise)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
  12. 4 Shares withheld for taxes Ho Tony W gave up 14,631 shares (to pay taxes)
  13. 4 Open-market sale Director sold 7,500 shares at $62.00 ($465,000)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 18 of 26 · 502 filings